We found that all tumors we examined in this study showed a higher expression level of CD8 than CD4. We also identified a high expression level of FOXP3, a marker of regulatory T cells, suggesting a significant proportion of CD4+ T cells in the tumor microenvironment may belong to T cells with immune suppressive functions. This evidence concerns the gene CD4 and neoplasm.